Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05163223
Title Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)
Acronym Cornerstone001
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aston Sci. Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ironwood Cancer and Research Centers Chandler Arizona 85224 United States Details
Scripps Health La Jolla California 92037 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Nebraska Cancer Specialist Omaha Nebraska 68130 United States Details
Gabrail Cancer Center Research Canton Ohio 44718 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43623 United States Details
Toledo Clinic Cancer Center Toledo Ohio 43623 United States Details
Providence Cancer Institute Portland Oregon 97213 United States Details
University of Washington Seattle Washington 98109 United States Details
Changhua Christian Hospital Changhua City 500 Taiwan Details
Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung 80756 Taiwan Details
China Medical University Hospital Taichung City 404 Taiwan Details
Chi Mei Medical Center Tainan 710 Taiwan Details
Koo Foundation Sun Yat-Sen Cancer Center Taipei city 11259 Taiwan Details
National Taiwan University Hospital Taipei City 112 Taiwan Details
Taipei Veterans General Hospital Taipei City 112 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field